
Publikationen von Yvonne Genzel
Alle Typen
Zeitschriftenartikel (109)
1.
Zeitschriftenartikel
354, 128769 (2025)
Streamlining the purification of a clinical-grade oncolytic virus for therapeutic applications. Separation and Purification Technology 2.
Zeitschriftenartikel
25 (5), e70022 (2025)
Process Intensification for Recombinant Marburg Virus Glycoprotein Production UsingDrosophilaS2 Cells. Engineering in Life Sciences 3.
Zeitschriftenartikel
109, 74 (2025)
Quantification of intracellular influenza A virus protein dynamics in different host cells after seed virus adaptation. Applied Microbiology and Biotechnology 4.
Zeitschriftenartikel
25 (4), e70027 (2025)
Influenza A Virus Production Following Quality by Design Principles. Engineering in Life Sciences 5.
Zeitschriftenartikel
13 (5), 1286 (2025)
Seed Train Intensification and TFDF-Based Perfusion for MDCK Cell-Based Influenza A Virus Production. Processes 6.
Zeitschriftenartikel
12 (7), 755 (2024)
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. Vaccines 7.
Zeitschriftenartikel
108 (1), 240 (2024)
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology 8.
Zeitschriftenartikel
108, 97 (2024)
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology 9.
Zeitschriftenartikel
24 (4), 2300245 (2024)
From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences 10.
Zeitschriftenartikel
20 (1), 2373521 (2024)
Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations. Human Vaccines & Immunotherapeutics 11.
Zeitschriftenartikel
13, 20936 (2023)
Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice. Scientific Reports 12.
Zeitschriftenartikel
120 (9), S. 2639 - 2657 (2023)
Process intensification strategies toward cell culture‐based high‐yield production of a fusogenic oncolytic virus. Biotechnology and Bioengineering 13.
Zeitschriftenartikel
120, S. 3335 - 3346 (2023)
Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus. Biotechnology and Bioengineering 14.
Zeitschriftenartikel
107, S. 5947 - 5961 (2023)
Production of retroviral vectors in continuous high cell density culture. Applied Microbiology and Biotechnology 15.
Zeitschriftenartikel
11, 1076524 (2023)
Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactors. Frontiers in Bioengineering and Biotechnology 16.
Zeitschriftenartikel
106, S. 4945 - 4961 (2022)
Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures. Applied Microbiology and Biotechnology 17.
Zeitschriftenartikel
259, 104544 (2022)
Absolute quantification of viral proteins during single-round replication of MDCK suspension cells. Journal of Proteomics 18.
Zeitschriftenartikel
11 (22), 3634 (2022)
Human 3D Airway Tissue Models for Real-Time Microscopy: Visualizing Respiratory Virus Spreading. Cells 19.
Zeitschriftenartikel
10 (2), 249 (2022)
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor. Vaccines 20.
Zeitschriftenartikel
12 (3), 239 (2022)
Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model. Metabolites